Thinksulin

Gratuit

1.6.1for iPhone, iPad

Agency for Clinical Innovation

Developer

16,5 Mo

Size

Apr 21, 2023

Update Date

Medical

Category

17+

Age Rating

App Store Site Web du développeur

Age Rating

Apps in this category do not contain restricted content.

Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

Thinksulin Captures d'écran

iPad

iPhone

About Thinksulin

Thinksulin was developed by ACI in consultation with the NSW Diabetes Taskforce and its In-hospital Management of Diabetes Mellitus Working Group and informed by: an evidence check of best practice care components of inpatient insulin management brokered by the Sax Institute for the Agency for Clinical Innovation (2017); clinician and consumer consultations; and clinical expertise.

Thinksulin aims to enhance the capacity and/or capability of junior medical officers and nursing staff responsible for prescribing and administering of insulin to patients in hospital with diabetes, although it can be used by any clinician responsible for the care of people in hospital with diabetes.
Thinksulin is a point of care app that provides information and decision support on blood glucose level targets, hypoglycaemia management, blood glucose monitoring, basal-bolus calculations, and charting and reviewing doses.

Quoi de neuf dans la dernière version 1.6.1

Last updated on Apr 21, 2023

Vieilles Versions

Updates for new iOS versions
SGLT2i information updated throughout the application to reflect the new evidence and guidelines around usage, particularly with regard to the perioperative period.

Version History

1.6.1

Apr 21, 2023

Updates for new iOS versions
SGLT2i information updated throughout the application to reflect the new evidence and guidelines around usage, particularly with regard to the perioperative period.

1.6.0

Sep 9, 2020

Lantus insulin was discontinued from 1st July 2020. Optisulin and Semglee are available alternative forms of insulin glargine, and this has been reflected in this version.

1.5.0

Oct 28, 2019

Bug fixes

1.4.0

Feb 13, 2019

Bug fixes

1.3

May 11, 2018

stability improvements and bug fixes

1.2

Apr 9, 2018

stability improvements